// App-Quantinova.ai

Mo1685 : Opposite NOS2-Mediated Roles for Epidermal Growth Factor and Indomethacin in Immature Human Intestinal Inflammation

Researchers

Presenter

  • Eric Tremblay

Principal Investigators

  • David Grynspan

  • Marcos Bettolli

  • Karolina M. Burghardt

  • Corentin Babakissa

  • Emile Levy

  • Ernest G. Seidman

  • Daniel Menard

  • Jean-Francois Beaulieu

Medical Centers

  • Research Consortium on Child Intestinal Inflammation, Division of Neonatology, Department of Paediatrics, University of Ottawa, Ottawa, ON, Canada

  • Research Consortium on Child Intestinal Inflammation, Department of Pediatrics, University of Sherbrooke, Sherbrooke, QC, Canada

  • Research Consortium on Child Intestinal Inflammation, Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, ON, Canada

  • Research Consortium on Child Intestinal Inflammation, Department of Surgery, University of Ottawa, Ottawa, ON, Canada

  • Research Consortium on Child Intestinal Inflammation, Department of Gastroenterology, McGill University, Montreal, QC, Canada

  • Research Consortium on Child Intestinal Inflammation, Department of Pathology and Laboratory of medicine, University of Ottawa, Ottawa, ON, Canada

  • Research Consortium on Child Intestinal Inflammation, Department of Pediatrics, University of Sherbrooke, Sherbrooke, QC, Canada

  • Research Consortium on Child Intestinal Inflammation, Department of Nutrition, CHU Ste-Justine, Universite de Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nitric oxide

  • Claudin1

  • Epidermal growth factor

Drug/Treatment

  • Indomethacin

  • Nitric oxide

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim